LPL Financial’s Innovator IBD ETF Leaders ETF LDRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-13,312
Closed -$356K 4347
2021
Q1
$356K Buy
+13,312
New +$381K ﹤0.01% 3339
2020
Q2
Sell
-10,057
Closed -$187K 3535
2020
Q1
$187K Sell
10,057
-8,572
-46% -$183K ﹤0.01% 2837
2019
Q4
$420K Sell
18,629
-1,287
-6% -$28.5K ﹤0.01% 2516
2019
Q3
$438K Sell
19,916
-2,971
-13% -$65K ﹤0.01% 2365
2019
Q2
$485K Sell
22,887
-3,382
-13% -$71.4K ﹤0.01% 2317
2019
Q1
$562K Sell
26,269
-3,433
-12% -$73.5K ﹤0.01% 2143
2018
Q4
$635K Sell
29,702
-4,882
-14% -$112K ﹤0.01% 1861
2018
Q3
$878K Buy
34,584
+2,265
+7% +$57.5K ﹤0.01% 1771
2018
Q2
$814K Sell
32,319
-18,897
-37% -$467K ﹤0.01% 1774
2018
Q1
$1.26M Buy
+51,216
New +$1.32M ﹤0.01% 1434

Other funds holding LDRS

LPL Financial's LDRS Position: Q2 2021 in Review

LPL Financial sold out of Innovator IBD ETF Leaders ETF (LDRS) in Q2 2021, closing a stake of 13,312 shares — an estimated $356K sold.

LPL Financial first reported a position in LDRS in Q1 2018 and held it in 10 quarters. The position peaked at $1.26M in Q1 2018. 3 funds tracked by Wall St. Rank hold LDRS as of Q2 2021.

  • LPL Financial reported no remaining Innovator IBD ETF Leaders ETF position as of Q2 2021 after selling out during the quarter.
  • LPL Financial sold 13,312 Innovator IBD ETF Leaders ETF shares in Q2 2021, an estimated $356K.
  • LPL Financial first reported a position in Innovator IBD ETF Leaders ETF in Q1 2018 and held it in 10 quarters.
  • LPL Financial's Innovator IBD ETF Leaders ETF position peaked at $1.26M in Q1 2018.
  • 3 funds tracked by Wall St. Rank held Innovator IBD ETF Leaders ETF as of Q2 2021.

Based on LPL Financial's 13F filing for Q2 2021, filed 13 Aug 2021.